T he use of autologous fat grafting is not a new concept in the field of plastic and reconstructive surgery. Van der Meulen first documented the idea of harvesting and transplanting fat to correct soft-tissue defects in the late nineteenth century. 1, 2 In 1895, Czerny first described fat grafting for breast reconstruction to improve lumpectomy defects. 3 However, fat grafting lacked widespread acceptance secondary to a high incidence of fat necrosis and cumbersome techniques for tissue transfer.
In recent years, Coleman and others have offered significant advancements in fat transfer to minimize the incidence of necrosis and improve aesthetic outcomes. [3] [4] [5] [6] [7] [8] Thus, plastic surgeons have witnessed resurgence in the use of autologous fat as a tool for correcting primary and secondary breast deformities. Fat transfer not only offers a natural alternative to alloplastic implants but is unique in its ability to transfer small quantities of fat to localized areas of deficiency.
A wealth of literature has emerged focusing on issues such as ideal medium, harvesting and trans-ferring techniques, and postoperative complications in relation to breast cancer screening. 8 -11 One area, however, that has yet to be studied well is the quantification of fat survival after transfer. The distribution patterns after fat injection remain entirely unknown. Spear and Coleman have reported the use of two-dimensional photography to evaluate the degree of improvement following fat grafting, but this approach has significant limitations. Specific morphometric values (breast volume, symmetry, breast shape, and contour) remain outside the scope of such analytic methods. Attempts to integrate more objective measuring tools such as water displacement, thermophilic casting, and magnetic resonance imaging-constructed three-dimensional models have been limited because of their cumbersome and time-consuming nature. [12] [13] [14] [15] [16] Thus, no accurate and reproducible tool exists with which to quantify the outcomes after fat transfer.
Three-dimensional photography has already been shown to be a valuable resource for the assessment of symmetry, shape, and contour. Our group has recently shown three-dimensional surface imaging as a useful device to accurately quantify the volumetric changes during the postoperative period following aesthetic and reconstructive breast surgery. 17 Based on this work, we introduced a novel analytical concept of mammometrics to quantify breast volume and shape. [17] [18] [19] This work serves as the foundation of the following article, which quantifies for the first time the amount of volume retention following autologous fat transfer to the breast. Thus, three-dimensional imaging may help achieve an objective approach for analyzing surgical outcomes of autologous fat transfer in terms of volumetric survival, shape preservation, and fat graft migration.
PATIENTS AND METHODS
Patients undergoing autologous fat injection surgery to the breast were offered enrollment into this study. Categories of patients included (1) revision of autologous breast reconstruction, (2) revision of implant-based breast reconstruction, and (3) revision after lumpectomy/partial mastectomy surgery. All patients were treated by one of the senior authors (N.S.K. or M.C.). Informed consent was obtained in accordance with the New York University Medical Center Institutional Review Board. All operations were performed using a modified Coleman technique in a closed system. Fat was harvested by suction-assisted lipectomy and transferred to a standard centrifuge at 3000 rpm for 3 minutes, and the middle layer of cells was injected into the recipient tissue. 8 The amount of fat injected and the injection sites were recorded intraoperatively for each revised breast.
Three-Dimensional Imaging and Volumetric Analysis
The imaging modality used was similar to that described in previous works by our group, 17 where the Canfield Vectra 3 pod system (Canfield Scientific, Fairfield, N.J.) captures the images (Fig.  1 ). Images were obtained preoperatively and at the standard subsequent postoperative visits routinely followed by the senior authors. On average, these visits were 7, 16, 49, and 140 days postoperatively. At those time points, three-dimensional measurements were calculated.
Constructed surface scans were imported into a secondary three-dimensional software program (Geomagic Studio 11; Geomagic, Inc., Research Triangle Park, N.C.) for all volumetric data analysis. Breast volumes were calculated using an established algorithm as described in previous work by our group. [17] [18] [19] All preoperative and postoperative breast images were aligned to reference x, y, and z coordinate axes, and total breast volume was computed for each breast. Breast volumes were recorded in cubic centimeter pixels (1 cm 3 ϭ 1 cc). A sample timeline of breast images and associated volumes are shown in Figure 2 .
RESULTS
In this study, 90 patients (123 breasts; average age, 49.6 years) underwent fat grafting. The body mass index for all patients did not have any statistically significant changes over the time period of this study. Of note, there were no complications (i.e., infections or hematomas) after fat grafting.
The patients were stratified into subgroups to analyze significant relationships between fat grafting and the recipient tissue. The first data breakdown divided the patients into three subgroups with statistically significant parameters based on the volume of fat injected. The first group (40 breasts) received the largest volume of fat (range, 111 to 216 cc), with an average injection volume of 151 cc, and retained 86.9 percent volume after 7 days, 81.1 percent at 16 days, 57.5 percent at 49 days, and 52.3 percent at 140 days. These findings contrast with the patients (42 breasts) who received a smaller fat volume, who had an average injection volume of 51 cc (range, 12 to 72 cc), and maintained 87.9 percent volume after 7 days, 75.8 percent by 16 days, 56.6 percent at 49 days, and 27.1 percent at 140 days. The third patient group (41 breasts) received an intermediate volume (range, 75 to 108 cc) of fat grafting, with an average injected volume of 93 cc, and retained 90.3 percent volume after 7 days, 74.0 percent by 16 days, 45.7 percent at 49 days, and 38.1 percent at 140 days. At the last time point, the largest injection volume subset demonstrated a statistically significant higher volumetric retention in comparison with the other two groups; no other time points were statistically significant (Fig. 3) .
The second patient stratification divided patients into those who received radiation therapy and those who did not. In the observed time period, there were 28 irradiated breasts and 95 breasts that were not irradiated. Average fat injected into the breast was 97.58 cc for the nonirradiated breasts and 105.04 cc for the irradiated breasts. In the irradiated subset, patients underwent fat grafting approximately 1.5 years after radiation treatment. For the nonirradiated breasts, at 7 days postoperatively, the breasts had 88.7 percent volume retention; at 16 days postoperatively, 75.5 percent volume retention; at 49 days postoperatively, 57.3 percent volume retention; and at 140 days, 43.3 percent volume retention. For the irradiated breasts, at 7 days postoperatively, the breasts had 86.7 percent volume retention; at 16 days postoperatively, 69.7 percent volume retention; at 49 days postoperatively, 59.8 percent volume retention; and at 140 days, 41.7 percent volume retention. No statistical difference was found between the two groups at any time point (Fig. 4) .
The third patient classification divided patients into subgroups based on type of prior surgery: 12 lumpectomy breasts (11 patients), 32 autologous reconstruction breasts (19 patients), and 79 implant reconstruction breasts (51 patients). For the lumpectomy breast patients, at 7 days postoperatively, the breasts had 92.4 percent volume retention; at 16 days postoperatively, 73.2 percent volume retention; at 49 days postoperatively, 59.4 percent volume retention; and at 140 days, 56.3 percent volume retention. For the autologous reconstruction patients, at 7 days postoperatively, the breasts had 87.5 percent volume retention; at 16 days postoperatively, 81.5 percent volume retention; at 49 days postoperatively, 59.0 percent volume retention; and at 140 days, 31.4 percent volume retention. For the implant reconstruction patients, at 7 days postoperatively, the breasts had 87.7 percent volume retention; at 16 days postoperatively, 72.7 percent volume retention; at 49 days postoperatively, 58.5 percent volume retention; and at 140 days, 42.2 percent volume retention. At postoperative day 7, the lumpectomy reconstruction subset had statistically significant higher volume retention than the autologous reconstruction subset. At postoperative day 16, the Volume 131, Number 2 • Analysis of Fat Graft Survival autologous reconstruction subset had statistically significant higher volume retention than the implant reconstruction subset. No other statistical difference was found among the three groups at the various time points (Fig. 5) .
DISCUSSION
Various advancements have been made in the techniques of fat graft harvest and delivery, but our ability to judge the overall success of fat grafting objectively remains limited. Previously, we reported the use of three-dimensional imaging to assess breast morphology in patients undergoing reduction mammaplasty, breast augmentation, and breast reconstruction. This study applied similar three-dimensional imaging technology to quantify objectively the percentage of volume retention after fat grafting to the breast after lumpectomy, autologous breast reconstruction, and implant-based reconstruction.
Resorption of volume after autologous fat transfer to the breast is a well-documented phenomenon.
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Our three-dimensional data affirm these subjective findings and quantify certain trends associ- Quantitative preoperative breast dimensions may provide a blueprint with which to outline the amount of fat to be harvested, total volume to be infused, and location of injection to mimic the size and shape of the nonaffected opposite breast. For example, in patients with unilateral breast fat grafting, the average preoperative breast volume before fat grafting was 190.069 Ϯ 64.285 cc, with the average contralateral noninjected breast volume of 261.357 Ϯ 56.733 cc. Two months postoperatively, we found that the breast with fat injection had a volume of 286.199 Ϯ 84.817 cc, an 8.68 percent difference in volume compared with the contralateral nonoperated side. These findings suggest that three-dimensional imaging may provide a resource to aid in presurgical planning and postoperative assessment to achieve symmetrical results.
Three-dimensional analysis provides a tool with which to monitor percentage retention associated with fat transfer and also to examine fat retention in different recipient sites. In this study, the patient population is subdivided into the following recipient sites: implant breast reconstruction, breast lumpectomy defects, and autologous breast reconstruction. We observe some statistically significant differences in volume retention in the early postoperative period, most likely secondary to acute inflammation and edema. However, these findings equalize at 49 days and 140 days; at these time points, the data identify an insignificant relationship between breast reconstruction type and percentage volume retention. Even though these recipient sites have varied composite tissues, they may behave similarly, as they all have some degree of autologous fat in the recipient subcutaneous plane. Long-term and larger studies are needed to affirm the presumed dynamics of the recipient tissue after autologous fat transfer.
Furthermore, three-dimensional analysis offers a method for examining trends associated with irradiated tissue and fat transfer. Radiation therapy for breast cancer alters underlying tissue perfusion and oxygenation, which can result in skin discoloration, subcutaneous tissue fibrosis, and associated capsular contracture of the reconstructed breast. In conjunction with these observed changes of irradiated tissue, our data identify intermittently smaller volume retention after fat transfer, but this finding is not statistically significant. Long-term and larger studies are needed to affirm the presumed dynamics of the irradiated breast after autologous fat transfer.
The success of three-dimensional imaging to assess the viability of the breast after fat transfer provides a template with which to monitor postoperative changes of other surgical sites. Areas such as the face and the abdomen have discrete anatomical landmarks and thus could follow a similar protocol of image acquisition and data analysis to monitor postsurgical progression. Eventually, three-dimensional imaging and analysis will offer a detailed description of body asymmetry and provide a blueprint for surgical reconstruction with fat transfer.
This protocol allows for further evaluation of various donor sites. In this study, the senior authors harvested fat from various areas of the body for transfer to the breast; however, no study currently exists to delineate the ideal donor site of adipose tissue for breast reconstruction. Three-dimensional surface imaging now outlines a method to determine the outcome of fat grafting based on the viability of various anatomical sites and may eventually stipulate the ideal donor site.
Previous works have supported the validity of three-dimensional analysis, and in this study, the nonmodified breast provided an internal control reaffirming the accuracy of this technique. These findings confirm the success and precision of three-dimensional analysis as a useful tool to aid in preoperative planning and postsurgical outcomes.
CONCLUSIONS
This study applies three-dimensional imaging technology to analyze objective changes in breast shape following autologous fat transfer. Patients receiving larger volumes of fat injection retain more volume long term, and larger volume fat injection patients achieve volume stabilization faster. Across all groups, approximately 40 to 50 percent of the injected fat volume survives long term. Radiation therapy and recipient site appear to have no effect on the volume of fat that survives; however, longer term studies are needed to differentiate definitive trends.
